NorthWest Biotherapeutics Inc (NWBO)

[Slave1]

You’re ignoring the distinction that matters: DCVax-L isn’t just autologous, it’s a cryopreserved, multi-dose, patient-specific vaccine manufactured with tumor lysate, not a shared antigen or fixed design. The MHRA had never reviewed or approved a therapy with this structure, delivery model, or logistical complexity. Pretending otherwise is either misinformed or deliberately misleading.